PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-07-28

Date Title Company
28-Jul-2022 Biotest AG: Biotest increases EBITDA in first half-year by 52% to 8.8 million EUR Biotest AG
28-Jul-2022 Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Is Anticipated to Grow at A Robust CAGR Of 4.7% Between 2022 And 2028 MARKITWIRED
28-Jul-2022 Insights On The GLP-1 Receptor Agonist Market To 2030 – Key Drivers, Restraints and Opportunities MARKITWIRED
28-Jul-2022 Animal Artificial Insemination Market Is Set to Experience a Significant Growth Of 5.6% CAGR From 2021 To 2031 MARKITWIRED
28-Jul-2022 Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022 Drägerwerk AG & Co. KGaA
28-Jul-2022 Amniotic Membranes Market Is Projected to Grow Significantly to Reach US$ 2.3 Billion By the Year 2028 MARKITWIRED
28-Jul-2022 Insights On the Pharmacovigilance Market To 2031 – Key Drivers, Restraints and Opportunities MARKITWIRED
28-Jul-2022 Gamma Knife Market Is Projected to Grow Significantly to Reach US$ 507.0 Million By the Year 2031 MARKITWIRED
28-Jul-2022 Spexis provides business update Spexis AG
28-Jul-2022 Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance Cosmo Pharmaceuticals N.V.
28-Jul-2022 Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease Relief Therapeutics Holding SA
28-Jul-2022 Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China Cosmo Pharmaceuticals N.V.
28-Jul-2022 Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs Relief Therapeutics Holding SA